scholarly journals PD-009 Safety and efficacy of FOLFOXIRI with or without targeted agents as first-line treatment of selected elderly metastatic colorectal cancer patients: a pooled analysis of GONO studies

2016 ◽  
Vol 27 ◽  
pp. ii104
Author(s):  
M. Casagrande ◽  
R. Moretto ◽  
F. Loupakis ◽  
C. Cremolini ◽  
G. Masi ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Pooled Analysis ◽  
Line Treatment ◽  
Targeted Agents ◽  
First Line ◽  
Safety And Efficacy ◽  
Colorectal Cancer Patients ◽  
First Line Treatment

scholarly journals IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients

Oncotarget ◽  
2017 ◽  
Vol 8 (10) ◽  
pp. 16887-16898 ◽  
Author(s):  
Mariantonietta Di Salvatore ◽  
Filippo Pietrantonio ◽  
Armando Orlandi ◽  
Marzia Del Re ◽  
Rosa Berenato ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Treatment Outcomes ◽  
Cancer Patients ◽  
Line Treatment ◽  
First Line ◽  
Colorectal Cancer Patients ◽  
Enos Polymorphisms ◽  
First Line Treatment

The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysis

2018 ◽  
Vol 125 ◽  
pp. 69-77 ◽  
Author(s):  
Domenico Ciliberto ◽  
Nicoletta Staropoli ◽  
Francesca Caglioti ◽  
Silvia Chiellino ◽  
Antonella Ierardi ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Meta Analysis ◽  
Line Treatment ◽  
Wild Type ◽  
First Line ◽  
Colorectal Cancer Patients ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document